Celcuity (CELC) Operating Leases (2019 - 2025)

Celcuity (CELC) posted Operating Leases of $54000.0 for Q4 2025, up 315.38% on a QoQ basis from $13000.0 in Q1 2025, and little changed year-over-year from $54000.0 in Q4 2024.

Celcuity (CELC) Operating Leases (2019 - 2025) Analysis & Trends

Celcuity's Operating Leases history runs 7 years deep, the most recent figure standing at $54000.0 for Q4 2025.

  • Quarterly Operating Leases changed 0.0% year-over-year to $54000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $54000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $54000.0, changed 0.0% from the prior year.
  • Operating Leases was $54000.0 for Q4 2025 at Celcuity, up from $13000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $363961.0 in Q1 2023 and bottomed at $13000.0 in Q1 2025.
  • A 5-year average of $154218.7 and a median of $138533.0 in 2024 frame the typical range for Operating Leases.
  • Annual changes were most pronounced in 2022 — Operating Leases surged 1251.44% — and 2025, when it tumbled 92.86%.
  • Celcuity's Operating Leases stood at $61771.0 in 2021, then slipped by 1.24% to $61002.0 in 2022, then jumped by 270.35% to $225922.0 in 2023, then sank by 76.1% to $54000.0 in 2024, then changed by 0.0% to $54000.0 in 2025.
  • Business Quant data shows CELC's Operating Leases at $54000.0 in Q4 2025, $13000.0 in Q1 2025, and $54000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Celcuity 4.13 Bn 4.13 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 54,000.00
Mar 31, 2025 13,000.00
Dec 31, 2024 54,000.00
Sep 30, 2024 95,699.00
Jun 30, 2024 138,533.00
Mar 31, 2024 182,079.00
Dec 31, 2023 225,922.00
Sep 30, 2023 270,925.00
Jun 30, 2023 317,120.00
Mar 31, 2023 363,961.00
Dec 31, 2022 61,002.00
Sep 30, 2022 107,830.00
Jun 30, 2022 156,769.00
Mar 31, 2022 204,595.00
Dec 31, 2021 61,771.00
Sep 30, 2021 299,373.00
Mar 31, 2021 15,139.00
Dec 31, 2020 53,000.00
Sep 30, 2020 107,040.00
Mar 31, 2020 176,600.00